Recruiting Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder NCT04421248 Conditions Attention Deficit Hyperactivity Disorder Combined Locations Kennedy Krieger Institute — Baltimore, Maryland, United States Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States View Trial Details
Completed Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. NCT05631626 Conditions ADHD, ADHD - Combined Type, Attention Deficit Disorder with Hyperactivity, +5 more Locations Clinical Research of Southern Nevada, LLC — Las Vegas, Nevada, United States View Trial Details
Completed Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 NCT05286762 Conditions ADHD, ADHD - Combined Type, Attention Deficit Disorder with Hyperactivity, +7 more Locations Clinical Neuroscience Solutions, Inc. — Jacksonville, Florida, United States Meridien Research — Maitland, Florida, United States Clinical Neuroscience Solutions, Inc. — Orlando, Florida, United States Atlanta Center for Medical Research — Atlanta, Georgia, United States View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Evaluating the Feasibility of FAM-SOTC Intervention for Families of Adolescents With ADHD: Pilot Study NCT04378517 Conditions Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder Combined, Attention Deficit and Disruptive Behavior Disorders, +2 more Locations University of Iceland, Faculty of Nursing — Reykjavik, Iceland View Trial Details
